Mopidamol

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMopidamol
Drug Alias Name莫哌达醇单哌潘生丁RapentonOLX-102RA-233
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsHead and Neck Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date1980/01/01
Country/TerritoryGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesN/A
Active IndicationsHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01XX
Related LinksN/A